Steve Allen

Chief Executive Officer
Bussiness Development
DNAe
United Arab Emirates

Business Expert Biomedical Sciences
Biography

  Steve Allen, Chief Executive Officer, joined DNAe in 2014. He is an experienced executive with a track record of growing a wide range of Life Science product and service companies, from start-ups to multinational corporations.  Before joining DNAe, Steve has held a number of leadership positions at PerkinElmer, Mettler-Toledo  and LGC Forensics. Having led the acquisition of over 15 companies and the successful launch of more than fifty new scientific products and services, Steve has used his experience to assist early stage companies to make the step change from scientific innovation to commercial success. This includes the Next Generation Sequencing startup Solexa, where he facilitated the development of the world’s leading whole genome analyzer, leading to the sale of the company to Illumina for $600 million.

Research Intrest

 Forensic Science, Sequencing